Your browser doesn't support javascript.
Quality Management for Point-Of-Care Testing of Pathogen Nucleic Acids: Chinese Expert Consensus.
Mo, Xi; Wang, Xueliang; Zhu, Zhaoqin; Yu, Yuetian; Chang, Dong; Zhang, Xinxin; Li, Dong; Sun, Fenyong; Zhou, Lin; Xu, Jin; Zhang, Hong; Gao, Chunfang; Guan, Ming; Xiao, Yanqun; Wu, Wenjuan.
  • Mo X; Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Wang X; Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, China.
  • Zhu Z; Department of Laboratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Yu Y; Department of Critical Care Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Chang D; Department of Laboratory Medicine, Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center, Shanghai, China.
  • Zhang X; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Rui Jin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Li D; Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Sun F; Department of Clinical Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Shanghai, China.
  • Zhou L; Department of Laboratory Medicine, Changzheng Hospital, Naval Medical University, Shanghai, China.
  • Xu J; Department of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
  • Zhang H; Department of Clinical Laboratory, Shanghai Children's Hospital, Shanghai, China.
  • Gao C; Clinical Laboratory Medicine Center, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China.
  • Guan M; Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xiao Y; Department of Molecular Biology, Shanghai Centre for Clinical Laboratory, Shanghai, China.
  • Wu W; Department of Laboratory Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Front Cell Infect Microbiol ; 11: 755508, 2021.
Article in English | MEDLINE | ID: covidwho-1497026
ABSTRACT
COVID-19 continues to circulate globally in 2021, while under the precise policy implementation of China's public health system, the epidemic was quickly controlled, and society and the economy have recovered. During the pandemic response, nucleic acid detection of SARS-CoV-2 has played an indispensable role in the first line of defence. In the cases of emergency operations or patients presenting at fever clinics, nucleic acid detection is required to be performed and reported quickly. Therefore, nucleic acid point-of-care testing (POCT) technology for SARS-CoV-2 identification has emerged, and has been widely carried out at all levels of medical institutions. SARS-CoV-2 POCT has served as a complementary test to conventional polymerase chain reaction (PCR) batch tests, thus forming an experimental diagnosis platform that not only guarantees medical safety but also improves quality services. However, in view of the complexity of molecular diagnosis and the biosafety requirements involved, pathogen nucleic acid POCT is different from traditional blood-based physical and chemical index detection. No guidelines currently exist for POCT quality management, and there have been inconsistencies documented in practical operation. Therefore, Shanghai Society of Molecular Diagnostics, Shanghai Society of Laboratory Medicine, Clinical Microbiology Division of Shanghai Society of Microbiology and Shanghai Center for Clinical Laboratory have cooperated with experts in laboratory medicine to generate the present expert consensus. Based on the current spectrum of major infectious diseases in China, the whole-process operation management of pathogen POCT, including its application scenarios, biosafety management, personnel qualification, performance verification, quality control, and result reporting, are described here. This expert consensus will aid in promoting the rational application and robust development of this technology in public health defence and hospital infection management.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nucleic Acids / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Cell Infect Microbiol Year: 2021 Document Type: Article Affiliation country: Fcimb.2021.755508

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Nucleic Acids / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: Front Cell Infect Microbiol Year: 2021 Document Type: Article Affiliation country: Fcimb.2021.755508